We are live on ! Find out more
XENT

Intersect ENT, Inc
XENT

Delisted

XENT was delisted on the 12th of May, 2022.

Back to rankings

112 hedge funds and large institutions have $521M invested in Intersect ENT, Inc in 2019 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 44 increasing their positions, 33 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

430% more call options, than puts

Call options by funds: $16.1M | Put options by funds: $3.05M

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

33% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 33

0% more funds holding

Funds holding: 112 → 112 (0)

0% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 20

25% less capital invested

Capital invested by funds: $690M → $521M (-$169M)

Holders
112
Holders Change
–
Holders Change %
0%
% of All Funds
2.46%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
20
Increased
44
Reduced
33
Closed
20
Calls
$16.1M
Puts
$3.05M
Net Calls
+$13.1M
Net Calls Change
+$2.12M

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$25.3M
2
BC
Broadfin Capital
New York
+$14.2M
3
FLAM
First Light Asset Management
Minnesota
+$9.96M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$7.28M
5
PVI
Pura Vida Investments
New York
+$6.54M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$31.5M
2
Millennium Management
Millennium Management
New York
-$16.2M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$11.9M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$7.98M
5
HM
HealthCor Management
New York
-$4.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$52.9M – – –
HM
2
HealthCor Management
New York
$43.2M -$4.26M -234,265 -8%
BlackRock
3
BlackRock
New York
$41.8M +$1.42M +78,100 +3%
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$34.4M -$7.98M -438,510 -18%
Vanguard Group
5
Vanguard Group
Pennsylvania
$27.5M +$681K +37,434 +2%
UBS Group
6
UBS Group
Switzerland
$23.6M +$25.3M +1,387,522 +56,449%
FLAM
7
First Light Asset Management
Minnesota
$20.7M +$9.96M +547,229 +82%
Wellington Management Group
8
Wellington Management Group
Massachusetts
$20.6M +$2.8M +153,937 +15%
Westfield Capital Management
9
Westfield Capital Management
Massachusetts
$20.4M -$311K -17,099 -1%
Adage Capital Partners
10
Adage Capital Partners
Massachusetts
$15.3M +$7.28M +400,000 +80%
RSCM
11
Rock Springs Capital Management
Maryland
$14.8M +$1.5M +82,500 +10%
BC
12
Broadfin Capital
New York
$13.3M +$14.2M +779,134 New
State Street
13
State Street
Massachusetts
$12.4M +$639K +35,130 +5%
PVI
14
Pura Vida Investments
New York
$11.4M +$6.54M +359,174 +116%
Man Group
15
Man Group
United Kingdom
$11.2M +$505K +27,762 +4%
Neuberger Berman Group
16
Neuberger Berman Group
New York
$11.2M +$2.85M +156,505 +31%
Morgan Stanley
17
Morgan Stanley
New York
$10.5M +$2.05M +112,392 +22%
Jennison Associates
18
Jennison Associates
New York
$10M +$2.15M +118,185 +25%
N
19
Nuveen
North Carolina
$9.83M +$295K +16,212 +3%
Artisan Partners
20
Artisan Partners
Wisconsin
$9.24M +$3.25M +178,724 +49%
BG
21
Bellevue Group
Switzerland
$7.8M +$143K +7,870 +2%
Invesco
22
Invesco
Georgia
$7.74M -$31.5M -1,732,389 -79%
Northern Trust
23
Northern Trust
Illinois
$7.34M +$428K +23,487 +6%
Geode Capital Management
24
Geode Capital Management
Massachusetts
$7.04M +$228K +12,541 +3%
Goldman Sachs
25
Goldman Sachs
New York
$6.57M -$146K -8,015 -2%
1
2 3 4 5

XENT Hedge Fund Activity: Q3 2019 in Review

112 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q3 2019, worth a combined $521M — down 25% from $690M a quarter earlier.

Fund positioning in XENT was balanced in Q3 2019: 20 funds opened new positions, 20 closed out, 44 added to existing stakes and 33 trimmed.

The largest buyer was UBS Group, adding an estimated $25.3M. The largest seller was Invesco, cutting an estimated $31.5M.

  • 112 institutional investors held Intersect ENT, Inc (XENT) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $521M of Intersect ENT, Inc stock for Q3 2019, down 25% quarter-over-quarter.
  • 20 funds opened new Intersect ENT, Inc positions in Q3 2019 and 20 closed out, a net change of 0 holders.
  • The largest Intersect ENT, Inc buyer in Q3 2019 was UBS Group, an estimated $25.3M added.
  • The largest Intersect ENT, Inc seller in Q3 2019 was Invesco, an estimated $31.5M sold.

Based on aggregated 13F filings for Q3 2019.